Fritextsökning
Innehållstyper
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Fabrik räddad i sista minuten
För några år sedan var det på håret att den anrika vaccintillverkningen i Solna skulle packas ihop och flyttas utomlands. Men tack vare en övertalningskampanj o...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
KI i open innovation-samarbete
Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
De ska basa över Scilifelab
I dag tog regeringen beslut om hur forskningscentrumet Scilifelab ska styras.
-
Safe and economic dispensing of powders
Mettler Toledo is showcasing Quantos, an automated dispenser for laboratory use.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Första cancerlinjen sekvenserad
- Kartläggningen visar att en del av en kromosom är borta, vilket kan ge en fingervisning om hur cancer uppstår, säger en av forskarna.